ArticleFrontiers in cardiovascular medicine2024
Construction and validation of a readmission risk prediction model for elderly patients with coronary heart disease.
Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning Prediction of One-Year Rehospitalization in Dementia: A Retrospective Cohort Study.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To investigate the risk factors for readmission of elderly patients with coronary artery disease, and to construct and validate a predictive model for readmission risk of elderly patients with coronary artery disease within 3 years by applying machine learning method. Methods: We selected 575 elderly patients with CHD admitted to the Affiliated Lu'an Hospital of Anhui Medical University from January 2020 to January 2023. Based on whether patients were readmitted within 3 years, they were divided into two groups: those readmitted within 3 years (215 patients) and those not readmitted within 3 years (360 patients). Lasso regression and multivariate logistic regression were used to compare the predictive value of these models. XGBoost, LR, RF, KNN and DT algorithms were used to build prediction models for readmission risk. ROC curves and calibration plots were used to evaluate the prediction performance of the model. For external validation, 143 patients who were admitted between February and June 2023 from a different associated hospital in Lu'an City were also used. Results: The XGBoost model demonstrated the most accurate prediction performance out of the five machine learning techniques. Diabetes, Red blood cell distribution width (RDW), and Triglyceride glucose-body mass index (TyG-BMI), as determined by Lasso regression and multivariate logistic regression. Calibration plot analysis demonstrated that the XGBoost model maintained strong calibration performance across both training and testing datasets, with calibration curves closely aligning with the ideal curve. This alignment signifies a high level of concordance between predicted probabilities and observed event rates. Additionally, decision curve analysis highlighted that both decision trees and XGBoost models achieved higher net benefits within the majority of threshold ranges, emphasizing their significant potential in clinical decision-making processes. The XGBoost model's area under the ROC curve (AUC) reached 0.903, while the external validation dataset yielded an AUC of 0.891, further validating the model's predictive accuracy and its ability to generalize across different datasets. Conclusion: TyG-BMI, RDW, and diabetes mellitus at the time of admission are the factors affecting readmission of elderly patients with coronary artery disease, and the model constructed based on the XGBoost algorithm for readmission risk prediction has good predictive efficacy, which can provide guidance for identifying high-risk patients and timely intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.